277 related articles for article (PubMed ID: 19648851)
1. The role of transdermal fentanyl patches in the effective management of cancer pain.
Gibbs M
Int J Palliat Nurs; 2009 Jul; 15(7):354-9. PubMed ID: 19648851
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
3. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
Tawfik MO; Bryuzgin V; Kourteva G;
Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
[TBL] [Abstract][Full Text] [Related]
4. The use of transdermal fentanyl in pediatric oncology palliative care.
Noyes M; Irving H
Am J Hosp Palliat Care; 2001; 18(6):411-6. PubMed ID: 11712724
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain.
Payne R
Semin Oncol; 1998 Jun; 25(3 Suppl 7):47-53. PubMed ID: 9671331
[TBL] [Abstract][Full Text] [Related]
6. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control.
Muijsers RB; Wagstaff AJ
Drugs; 2001; 61(15):2289-307. PubMed ID: 11772140
[TBL] [Abstract][Full Text] [Related]
7. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
Mitra F; Chowdhury S; Shelley M; Williams G
Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
[TBL] [Abstract][Full Text] [Related]
8. Managing breakthrough pain: a clinical review with three case studies using oral transmucosal fentanyl citrate.
Rhiner M; Palos G; Termini M
Clin J Oncol Nurs; 2004 Oct; 8(5):507-12. PubMed ID: 15515284
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
[TBL] [Abstract][Full Text] [Related]
10. [Fentanyl by buccal administration. Fifty to hundred times stronger than morphine against pain].
Taeron C
Rev Infirm; 2002 Sep; (83):47-9. PubMed ID: 12380268
[No Abstract] [Full Text] [Related]
11. Pharmacologic management of adult cancer pain.
Coyle N; Layman-Goldstein M
Oncology (Williston Park); 2007 Feb; 21(2 Suppl Nurse Ed):10-22; discussion 26. PubMed ID: 17474359
[TBL] [Abstract][Full Text] [Related]
12. Can fentanyl be systemically absorbed when administered vaginally? A feasibility study.
Fisher K; Stiles C; Heim B; Hagen NA
J Palliat Care; 2006; 22(1):54-6. PubMed ID: 16689417
[No Abstract] [Full Text] [Related]
13. Transdermal opioids for cancer pain.
Cachia E; Ahmedzai SH
Curr Opin Support Palliat Care; 2011 Mar; 5(1):15-9. PubMed ID: 21325999
[TBL] [Abstract][Full Text] [Related]
14. [Medico-legal aspects of the use of fentanyl patches].
Zimmermann M
Anaesthesist; 2006 Jun; 55(6):706-7. PubMed ID: 16609884
[TBL] [Abstract][Full Text] [Related]
15. An alternative algorithm for dosing transdermal fentanyl for cancer-related pain.
Breitbart W; Chandler S; Eagel B; Ellison N; Enck RE; Lefkowitz M; Payne R
Oncology (Williston Park); 2000 May; 14(5):695-705; discussion 705, 709-17. PubMed ID: 10853461
[TBL] [Abstract][Full Text] [Related]
16. Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients.
Solassol I; Caumette L; Bressolle F; Garcia F; Thézenas S; Astre C; Culine S; Coulouma R; Pinguet F
Oncol Rep; 2005 Oct; 14(4):1029-36. PubMed ID: 16142368
[TBL] [Abstract][Full Text] [Related]
17. Transdermal fentanyl: informed prescribing is essential.
Ross JR; Quigley C
Eur J Pain; 2003; 7(5):481-3. PubMed ID: 12935801
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cancer pain with transdermal fentanyl.
Gourlay GK
Lancet Oncol; 2001 Mar; 2(3):165-72. PubMed ID: 11902567
[TBL] [Abstract][Full Text] [Related]
19. Three-cycle fentanyl patch system significantly improves pain control in gynecologic cancer.
Kanamori C; Kanamori T; Hayashi M; Yorioka H; Kanzaki H
J Obstet Gynaecol Res; 2006 Dec; 32(6):605-9. PubMed ID: 17100824
[TBL] [Abstract][Full Text] [Related]
20. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
